JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
+$2.54B |
| 2 |
Amazon
AMZN
|
+$1.38B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$827M |
| 4 |
Public Service Enterprise Group
PEG
|
+$725M |
| 5 |
Union Pacific
UNP
|
+$721M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.49B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.03B |
| 3 |
McDonald's
MCD
|
+$1.01B |
| 4 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$871M |
| 5 |
Exelon
EXC
|
+$709M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.19% |
| 2 | Technology | 14.28% |
| 3 | Healthcare | 12.84% |
| 4 | Financials | 10.61% |
| 5 | Consumer Discretionary | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3126
PUT
Southwest Airlines
LUV
$20.8B
| $2.89M | ﹤0.01% |
85,700
-23,600
| -22% | -$851K |
2022 Q3
1 quarter
|
|
3127
Establishment Labs
ESTA
$1.95B
| $2.88M | ﹤0.01% |
43,943
-7,141
| -14% | -$431K |
2021 Q2
6 quarters
|
|
3128
Emergent Biosolutions
EBS
$356M
| $2.88M | ﹤0.01% |
244,243
+181,213
| +288% | +$2.8M |
2014 Q1
35 quarters
|
|
3129
WisdomTree India Earnings Fund ETF
EPI
$1.81B
| $2.88M | ﹤0.01% |
88,463
-936
| -1% | -$30.3K |
2013 Q2
38 quarters
|
|
|
KYNB
3130
Kyntra Bio
KYNB
$24.1M
| $2.88M | ﹤0.01% |
7,202
+1,527
| +27% | +$585K |
2014 Q4
32 quarters
|
|
3131
Korea Electric Power
KEP
$14.5B
| $2.88M | ﹤0.01% |
333,064
-219,335
| -40% | -$1.56M |
2015 Q4
28 quarters
|
|
|
GOOD
3132
Gladstone Commercial Corp
GOOD
$615M
| $2.87M | ﹤0.01% |
155,253
-276,817
| -64% | -$4.93M |
2013 Q3
37 quarters
|
|
|
ACH
3133
Accendra Health
ACH
$35.8M
| $2.87M | ﹤0.01% |
147,027
+12,703
| +9% | +$248K |
2013 Q2
38 quarters
|
|
3134
CALL
Hartford Financial Services
HIG
$34.3B
| $2.87M | ﹤0.01% |
37,800
+37,400
| +9,350% | +$2.69M |
2022 Q2
2 quarters
|
|
3135
Dime Commercial Bancshares
DCOM
$1.74B
| $2.86M | ﹤0.01% |
89,801
-10,663
| -11% | -$352K |
2013 Q2
38 quarters
|
|
3136
Collegium Pharmaceutical
COLL
$712M
| $2.86M | ﹤0.01% |
123,174
-23,774
| -16% | -$479K |
2017 Q3
21 quarters
|
|
3137
AllianzIM U.S. Equity Buffer20 Oct ETF
OCTW
$320M
| $2.86M | ﹤0.01% |
+102,673
| New | +$2.83M |
2022 Q4
0 quarters
|
|
3138
Carpenter Technology
CRS
$19.6B
| $2.85M | ﹤0.01% |
77,187
+5,657
| +8% | +$215K |
2013 Q2
38 quarters
|
|
3139
Invesco S&P 500 Low Volatility ETF
SPLV
$7.04B
| $2.85M | ﹤0.01% |
44,610
+18,720
| +72% | +$1.16M |
2013 Q2
38 quarters
|
|
3140
CALL
Halozyme
HALO
$12.5B
| $2.85M | ﹤0.01% |
50,000
-50,000
| -50% | -$2.56M |
2022 Q1
3 quarters
|
|
|
NGM
3141
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $2.85M | ﹤0.01% |
566,539
+32,642
| +6% | +$205K |
2019 Q2
14 quarters
|
|
3142
CALL
Yum! Brands
YUM
$38.2B
| $2.83M | ﹤0.01% |
22,100
-119,100
| -84% | -$14.4M |
2022 Q2
2 quarters
|
|
|
UHT
3143
Universal Health Realty Income Trust
UHT
$520M
| $2.83M | ﹤0.01% |
59,210
-11,463
| -16% | -$552K |
2013 Q2
38 quarters
|
|
|
LOKM
3144
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
| $2.82M | ﹤0.01% |
280,622
| – | – |
2021 Q4
4 quarters
|
|
3145
ZipRecruiter
ZIP
$303M
| $2.82M | ﹤0.01% |
171,740
+100,417
| +141% | +$1.67M |
2021 Q4
4 quarters
|
|
3146
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.64B
| $2.82M | ﹤0.01% |
33,288
| – | – |
2017 Q3
21 quarters
|
|
3147
CALL
DuPont de Nemours
DD
$18B
| $2.81M | ﹤0.01% |
32,663
+4,381
| +15% | +$350K |
2021 Q3
5 quarters
|
|
3148
CALL
Alexandria Real Estate Equities
ARE
$7.9B
| $2.81M | ﹤0.01% |
19,300
-19,000
| -50% | -$2.75M |
2022 Q3
1 quarter
|
|
3149
Marqeta
MQ
$1.72B
| $2.81M | ﹤0.01% |
115,002
-6,316
| -5% | -$172K |
2021 Q3
5 quarters
|
|
3150
CALL
CME Group
CME
$97.2B
| $2.81M | ﹤0.01% |
16,700
| – | – |
2021 Q1
7 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2022 Portfolio in Review
As of Q4 2022, JP Morgan Chase held 7,423 positions worth $759B, up 8.9% from $696B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q4 2022 filing shows 754 new, 2,939 increased, 2,285 reduced and 593 closed positions. Its largest new stake was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M. The largest sale was Invesco QQQ Trust, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2022 buy was Invesco S&P Emerging Markets Low Volatility ETF: 2,344,997 shares worth $54M.
- JP Morgan Chase added most to Vanguard Tax-Exempt Bond Index Fund in Q4 2022, an estimated $2.54B increase.
- JP Morgan Chase's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $1.49B.
- JP Morgan Chase fully exited Duke Realty Corp. in Q4 2022, selling an estimated $424M.
- JP Morgan Chase's ten largest holdings make up 16% of its $759B portfolio in Q4 2022.
- JP Morgan Chase opened 754 new positions and closed 593 in Q4 2022.
- JP Morgan Chase's portfolio value rose 8.9% quarter-over-quarter to $759B.
Based on JP Morgan Chase's 13F filing for Q4 2022, filed 13 Feb 2023.